Clinical updates, including trial initiations, enrollment status and data readouts and publications: Biolase, Stereotaxis.

Med-tech firms raising money in public or private financings, including: Nanoviricides, Novasight, Paige.

New hires and promotions in the med-tech industry, including: Orchestra Biomed, Viacyte.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: 3D Medical, Apollo Med Innovations, Aytu Bioscience, Beroni Group, Biosig Technologies, Bruker, EfficacyAI, Forsitech, Health Catalyst, Healthfinch, Inscopix, Medmira, Quantzig, Standard Capital, Todos Medical, Webbdx.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alnylam, Biontech, Clinigen, Cytodyn, Enzychem, Pfizer, Protokinetix.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: 2x, Angelini, Byondis, Cardior, Citius, Combigene, Cyclacel, Dewpoint, Exegi, Fresenius Kabi, Immunoprecise, Innovation, Kainomyx, Lipocine, Mateon, Menarini, Merck, Opgen, Oncology Venture, Ovid, PCI Biotech, Pear, Samsung, Stcube, Takeda, Tonix .

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Adverum, Arcutis, Avadel, Bellerophon, Biosig, Calithera, Catalyst, Celsion, Chugai, Freeline, Genentech, Junshi, Kodiak, Nextcure, Rocket, Spark, Summit, Trevi.

Biopharmas raising money in public or private financings, including: 89bio, Akero, ALX, Amgen, Beigene, Cumulus, FSD, Nanoviricides, Pandion, Qualigen, Spirea, Tonix, Vaxart, Vir.

New hires and promotions in the biopharma industry, including: 4Bio, Cerevel, Cytovance, Eyepoint, Kiadis, Nurix, Phathom, Turning Point, Vertex, Viacyte, Vir.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Infervision.